{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T03:57:06Z","timestamp":1771991826968,"version":"3.50.1"},"reference-count":21,"publisher":"American Society for Microbiology","issue":"11","license":[{"start":{"date-parts":[[2020,10,21]],"date-time":"2020-10-21T00:00:00Z","timestamp":1603238400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["J Clin Microbiol"],"published-print":{"date-parts":[[2020,10,21]]},"abstract":"<jats:p>\n            Azithromycin in combination with ceftriaxone is recommended as the first-line treatment for uncomplicated gonorrhea in many countries. Therefore, monitoring of azithromycin susceptibility of\n            <jats:named-content content-type=\"genus-species\">Neisseria gonorrhoeae<\/jats:named-content>\n            isolates is essential. In 2019, the Clinical and Laboratory Standards Institute (CLSI) listed the MIC breakpoint for a susceptible-only category to azithromycin, but breakpoints for disk diffusion are not yet available. In this study, we evaluated the usefulness of disk diffusion for testing the susceptibility of\n            <jats:named-content content-type=\"genus-species\">N. gonorrhoeae<\/jats:named-content>\n            isolates to azithromycin.\n          <\/jats:p>","DOI":"10.1128\/jcm.01398-20","type":"journal-article","created":{"date-parts":[[2020,8,13]],"date-time":"2020-08-13T13:05:10Z","timestamp":1597323910000},"update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":8,"title":["Testing of\n            <i>In Vitro<\/i>\n            Susceptibility of Neisseria gonorrhoeae to Azithromycin: Comparison of Disk Diffusion and Reference Agar Dilution Methods"],"prefix":"10.1128","volume":"58","author":[{"given":"Ricardo","family":"Gianecini","sequence":"first","affiliation":[{"name":"World Health Organization Collaborating Centre for Antimicrobial Resistance, National Reference Laboratory of Sexually Transmitted Diseases (STD), National Institute of Infectious Diseases-ANLIS Dr. Carlos G. Malbr\u00e1n, Buenos Aires, Argentina"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lucia","family":"Irazu","sequence":"additional","affiliation":[{"name":"National Institute of Infectious Diseases-ANLIS Dr. Carlos G. Malbr\u00e1n, Buenos Aires, Argentina"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcelo","family":"Rodr\u00edguez","sequence":"additional","affiliation":[{"name":"National Institute of Infectious Diseases-ANLIS Dr. Carlos G. Malbr\u00e1n, Buenos Aires, Argentina"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paula","family":"Cristaldo","sequence":"additional","affiliation":[{"name":"World Health Organization Collaborating Centre for Antimicrobial Resistance, National Reference Laboratory of Sexually Transmitted Diseases (STD), National Institute of Infectious Diseases-ANLIS Dr. Carlos G. Malbr\u00e1n, Buenos Aires, Argentina"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claudia","family":"Oviedo","sequence":"additional","affiliation":[{"name":"World Health Organization Collaborating Centre for Antimicrobial Resistance, National Reference Laboratory of Sexually Transmitted Diseases (STD), National Institute of Infectious Diseases-ANLIS Dr. Carlos G. Malbr\u00e1n, Buenos Aires, Argentina"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marisa","family":"Turco","sequence":"additional","affiliation":[{"name":"Secci\u00f3n Microbiolog\u00eda, Hospital de Ni\u00f1os Ricardo Guti\u00e9rrez, Buenos Aires, Argentina"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Veronica","family":"Rodrigo","sequence":"additional","affiliation":[{"name":"Secci\u00f3n Microbiolog\u00eda, Hospital de Ni\u00f1os Ricardo Guti\u00e9rrez, Buenos Aires, Argentina"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liliana Fern\u00e1ndez","family":"Canigia","sequence":"additional","affiliation":[{"name":"Laboratorio Bacteriolog\u00eda, Hospital Alem\u00e1n, Buenos Aires, Argentina"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana","family":"Schneider","sequence":"additional","affiliation":[{"name":"Laboratorio Bacteriolog\u00eda, Hospital Alem\u00e1n, Buenos Aires, Argentina"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liliana","family":"Guelfand","sequence":"additional","affiliation":[{"name":"Laboratorio Bacteriolog\u00eda, Hospital Fern\u00e1ndez, Buenos Aires, Argentina"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"Scocozza","sequence":"additional","affiliation":[{"name":"Laboratorio Bacteriolog\u00eda, Hospital Fern\u00e1ndez, Buenos Aires, Argentina"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"GASSP-AR Working Group","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5186-9222","authenticated-orcid":false,"given":"Patricia","family":"Galarza","sequence":"additional","affiliation":[{"name":"World Health Organization Collaborating Centre for Antimicrobial Resistance, National Reference Laboratory of Sexually Transmitted Diseases (STD), National Institute of Infectious Diseases-ANLIS Dr. Carlos G. Malbr\u00e1n, Buenos Aires, Argentina"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"235","reference":[{"key":"e_1_3_3_2_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1002344"},{"key":"e_1_3_3_3_2","doi-asserted-by":"publisher","DOI":"10.1177\/0956462412472837"},{"key":"e_1_3_3_4_2","first-page":"1","article-title":"Sexually transmitted diseases treatment guidelines, 2015","volume":"64","author":"Workowski KA","year":"2015","unstructured":"Workowski KA, Bolan GA, Centers for Disease Control and Prevention. 2015. Sexually transmitted diseases treatment guidelines, 2015. MMWR Recomm Rep 64:1\u2013137.","journal-title":"MMWR Recomm Rep"},{"key":"e_1_3_3_5_2","volume-title":"WHO guidelines for the treatment of Neisseria gonorrhoeae","author":"World Health Organization","year":"2016","unstructured":"World Health Organization. 2016. WHO guidelines for the treatment of Neisseria gonorrhoeae. World Health Organization, Geneva, Switzerland. http:\/\/www.who.int\/reproductivehealth\/publications\/rtis\/gonorrhoea-treatment-guidelines\/en\/."},{"key":"e_1_3_3_6_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMc1512757"},{"key":"e_1_3_3_7_2","doi-asserted-by":"publisher","DOI":"10.1071\/SH19023"},{"key":"e_1_3_3_8_2","volume-title":"Performance standards for antimicrobial susceptibility testing: twenty-ninth informational supplement M100-S29","author":"Clinical and Laboratory Standards Institute","year":"2019","unstructured":"Clinical and Laboratory Standards Institute. 2019. Performance standards for antimicrobial susceptibility testing: twenty-ninth informational supplement M100-S29. Clinical and Laboratory Standards Institute, Wayne, PA."},{"key":"e_1_3_3_9_2","doi-asserted-by":"publisher","DOI":"10.1099\/jmm.0.000651"},{"key":"e_1_3_3_10_2","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofx163.105"},{"key":"e_1_3_3_11_2","volume-title":"Laboratory diagnosis of sexually transmitted infections, including human immunodeficiency virus","author":"World Health Organization","year":"2013","unstructured":"World Health Organization. 2013. Laboratory diagnosis of sexually transmitted infections, including human immunodeficiency virus. World Health Organization, Geneva, Switzerland. http:\/\/apps.who.int\/iris\/bitstream\/10665\/85343\/1\/9789241505840_eng.pdf."},{"key":"e_1_3_3_12_2","volume-title":"CLSI document M07-A11","author":"Clinical and Laboratory Standards Institute","year":"2018","unstructured":"Clinical and Laboratory Standards Institute. 2018. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically; approved standard-eleventh edition, CLSI document M07-A11. Clinical and Laboratory Standards Institute, Wayne, PA."},{"key":"e_1_3_3_13_2","volume-title":"Performance standards for antimicrobial disk susceptibility tests; approved standard-thirteenth edition, CLSI document M02-A13","author":"Clinical and Laboratory Standards Institute","year":"2018","unstructured":"Clinical and Laboratory Standards Institute. 2018. Performance standards for antimicrobial disk susceptibility tests; approved standard-thirteenth edition, CLSI document M02-A13. Clinical and Laboratory Standards Institute, Wayne, PA."},{"key":"e_1_3_3_14_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkw288"},{"key":"e_1_3_3_15_2","volume-title":"Verification of commercial microbial identification and antimicrobial susceptibility testing systems; first edition CLSI guideline M52","author":"Clinical and Laboratory Standards Institute","year":"2015","unstructured":"Clinical and Laboratory Standards Institute. 2015. Verification of commercial microbial identification and antimicrobial susceptibility testing systems; first edition CLSI guideline M52. Clinical and Laboratory Standards Institute, Wayne, PA."},{"key":"e_1_3_3_16_2","volume-title":"Cumitech 31A, verification and validation of procedures in the clinical microbiology laboratory","author":"Clark RB","year":"2009","unstructured":"Clark RB, Lewinski MA, Loeffelholz MJ, Tibbetts RJ. 2009. Cumitech 31A, verification and validation of procedures in the clinical microbiology laboratory. In Sharp SE (ed), ASM Press, Washington, DC."},{"key":"e_1_3_3_17_2","doi-asserted-by":"publisher","DOI":"10.3201\/eid0102.950209"},{"key":"e_1_3_3_18_2","doi-asserted-by":"publisher","DOI":"10.1214\/aoms\/1177730491"},{"key":"e_1_3_3_19_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkp188"},{"key":"e_1_3_3_20_2","doi-asserted-by":"publisher","DOI":"10.2307\/2529310"},{"key":"e_1_3_3_21_2","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciz292"},{"key":"e_1_3_3_22_2","volume-title":"CLSI document M23-A5","author":"Clinical and Laboratory Standards Institute","year":"2018","unstructured":"Clinical and Laboratory Standards Institute. 2018. Development of in vitro susceptibility testing criteria and quality control parameters; approved guideline-fifth edition. CLSI document M23-A5. Clinical and Laboratory Standards Institute, Wayne, PA."}],"container-title":["Journal of Clinical Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/JCM.01398-20","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/JCM.01398-20","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,5]],"date-time":"2022-03-05T10:38:47Z","timestamp":1646476727000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/JCM.01398-20"}},"subtitle":[],"editor":[{"given":"Erik","family":"Munson","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2020,10,21]]},"references-count":21,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2020,10,21]]}},"alternative-id":["10.1128\/JCM.01398-20"],"URL":"https:\/\/doi.org\/10.1128\/jcm.01398-20","relation":{},"ISSN":["0095-1137","1098-660X"],"issn-type":[{"value":"0095-1137","type":"print"},{"value":"1098-660X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10,21]]},"assertion":[{"value":"2020-06-05","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-08-08","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-10-21","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e01398-20"}}